26. V.I. Shubayev, T.R. Pisanic 2nd, S. Jin, Magnetic nanoparticles for theragnostics. Adv. Drug
Deliv. Rev. 61, 467–477 (2009)
27. Y. Xing, J. Zhao, P.S. Conti, K. Chen, Radiolabeled nanoparticles for multimodality tumor
imaging. Theranostics 4(3), 290–306 (2014)
28. P. Bouziotis, D. Psimadas, T. Tsotakos, D. Stamopoulos, C. Tsoukalas, Radiolabeled iron
oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents. Curr. Top. Med.
Chem. 12, 2694–2702 (2012)
29. Y.-X.J. Wang, Superparamagnetic iron oxide based MRI contrast agents: Curr. Status Clin
Appl. Quant Imaging Med. Surg. 1, 35–40 (2011)
30. M.G. Harisinghani, J. Barentsz, P.F. Hahn, W.M. Deserno, S. Tabatabaei, C.H. van de Kaa
et al., Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
N. Engl. J. Med. 348, 2491–2499 (2003)
31. F.M. Kievit, M. Zhang, Surface engineering of iron oxide nanoparticles for targeted cancer
therapy. Acc. Chem. Res. 44, 853–862 (2011)
32. M.S. Judenhofer, H.F. Wehrl, D.F. Newport, C. Catana, S.B. Siegel, M. Becker et al.,
Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat.
Med. 14, 459–465 (2008)
33. F. Ai, C.A. Ferreira, F. Chen, W. Cai, Engineering of radiolabeled iron oxide nanoparticles
for dual-modality imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 8(4), 619–630
(2016)
34. M.S. Judenhofer, S.R. Cherry, Applications for preclinical PET/MRI. Semin. Nucl. Med. 43,
19–29 (2013)
35. H. Zaidi, A. Del Guerra, An outlook on future design of hybrid PET/MRI systems. Med.
Phys. 38, 5667–5689 (2011)
36. R. Madru, P. Kjellman, F. Olsson, K. Wingardh, C. Ingvar, F. Stahlberg et al.,
99m Tc-labeled
superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel
lymph nodes. J. Nucl. Med. 53, 459–463 (2012)
37. Y. Tang, C. Zhang, J. Wang, X. Lin, L. Zhang, Y. Yang et al., MRI/SPECT/Fluorescent
tri-Modal probe for evaluating the homing and therapeutic efficacy of transplanted
mesenchymal stem cells in a rat ischemic stroke model. Adv. Funct. Mater. 25, 1024–
1034 (2015)
38. J. Chen, S. Zhu, L. Tong, J. Li, F. Chen, Y. Han et al., Superparamagnetic iron oxide
nanoparticles mediated
131
I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth
in nude mice. BMC Cancer 14, 114 (2014)
39. S.I. Park, B.J. Kwon, J.H. Park, H. Jung, K.H. Yu, Synthesis and characterization of 3-[
131 I]
iodo-L-tyrosine grafted Fe 3 O 4 @SiO 2 nanocomposite for single photon emission computed
tomography (SPECT) and magnetic resonance imaging (MRI). J. Nanosci. Nanotechnol. 11,
1818–1821 (2011)
40. H. Zolata, F. Abbasi Davani, H. Afarideh, Synthesis, characterization and theranostic
evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles. Nucl. Med. Biol. 42, 164–170 (2015)
41. H. Wang, R. Kumar, D. Nagesha, R.I. Duclos, S. Sridhar, S.J. Gatley, Integrity of
111
In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse. Nucl. Med.
Biol. 42, 65–70 (2015)
42. J. Cao, Y. Wang, J. Yu, J. Xia, C. Zhang, D. Yin et al., Preparation and radiolabeling of
surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy. J. Magn. Mater. 277, 165–174 (2004)
43. R. Thomas, I.-K. Park, Y. Jeong, Magnetic iron oxide nanoparticles for multimodal imaging
and therapy of cancer. Int. J. Mol. Sci. 14, 15910–15930 (2013)
44. B.R. Jarrett, B. Gustafsson, D.L. Kukis, A.Y. Louie, Synthesis of
64
Cu-labeled magnetic
nanoparticles for multimodal imaging. Bioconjug. Chem. 19, 1496–1504 (2008)
2 Exogenous Radionanomedicine: Inorganic Nanomaterials
39
Deliv. Rev. 61, 467–477 (2009)
27. Y. Xing, J. Zhao, P.S. Conti, K. Chen, Radiolabeled nanoparticles for multimodality tumor
imaging. Theranostics 4(3), 290–306 (2014)
28. P. Bouziotis, D. Psimadas, T. Tsotakos, D. Stamopoulos, C. Tsoukalas, Radiolabeled iron
oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents. Curr. Top. Med.
Chem. 12, 2694–2702 (2012)
29. Y.-X.J. Wang, Superparamagnetic iron oxide based MRI contrast agents: Curr. Status Clin
Appl. Quant Imaging Med. Surg. 1, 35–40 (2011)
30. M.G. Harisinghani, J. Barentsz, P.F. Hahn, W.M. Deserno, S. Tabatabaei, C.H. van de Kaa
et al., Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
N. Engl. J. Med. 348, 2491–2499 (2003)
31. F.M. Kievit, M. Zhang, Surface engineering of iron oxide nanoparticles for targeted cancer
therapy. Acc. Chem. Res. 44, 853–862 (2011)
32. M.S. Judenhofer, H.F. Wehrl, D.F. Newport, C. Catana, S.B. Siegel, M. Becker et al.,
Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat.
Med. 14, 459–465 (2008)
33. F. Ai, C.A. Ferreira, F. Chen, W. Cai, Engineering of radiolabeled iron oxide nanoparticles
for dual-modality imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 8(4), 619–630
(2016)
34. M.S. Judenhofer, S.R. Cherry, Applications for preclinical PET/MRI. Semin. Nucl. Med. 43,
19–29 (2013)
35. H. Zaidi, A. Del Guerra, An outlook on future design of hybrid PET/MRI systems. Med.
Phys. 38, 5667–5689 (2011)
36. R. Madru, P. Kjellman, F. Olsson, K. Wingardh, C. Ingvar, F. Stahlberg et al.,
99m Tc-labeled
superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel
lymph nodes. J. Nucl. Med. 53, 459–463 (2012)
37. Y. Tang, C. Zhang, J. Wang, X. Lin, L. Zhang, Y. Yang et al., MRI/SPECT/Fluorescent
tri-Modal probe for evaluating the homing and therapeutic efficacy of transplanted
mesenchymal stem cells in a rat ischemic stroke model. Adv. Funct. Mater. 25, 1024–
1034 (2015)
38. J. Chen, S. Zhu, L. Tong, J. Li, F. Chen, Y. Han et al., Superparamagnetic iron oxide
nanoparticles mediated
131
I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth
in nude mice. BMC Cancer 14, 114 (2014)
39. S.I. Park, B.J. Kwon, J.H. Park, H. Jung, K.H. Yu, Synthesis and characterization of 3-[
131 I]
iodo-L-tyrosine grafted Fe 3 O 4 @SiO 2 nanocomposite for single photon emission computed
tomography (SPECT) and magnetic resonance imaging (MRI). J. Nanosci. Nanotechnol. 11,
1818–1821 (2011)
40. H. Zolata, F. Abbasi Davani, H. Afarideh, Synthesis, characterization and theranostic
evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles. Nucl. Med. Biol. 42, 164–170 (2015)
41. H. Wang, R. Kumar, D. Nagesha, R.I. Duclos, S. Sridhar, S.J. Gatley, Integrity of
111
In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse. Nucl. Med.
Biol. 42, 65–70 (2015)
42. J. Cao, Y. Wang, J. Yu, J. Xia, C. Zhang, D. Yin et al., Preparation and radiolabeling of
surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy. J. Magn. Mater. 277, 165–174 (2004)
43. R. Thomas, I.-K. Park, Y. Jeong, Magnetic iron oxide nanoparticles for multimodal imaging
and therapy of cancer. Int. J. Mol. Sci. 14, 15910–15930 (2013)
44. B.R. Jarrett, B. Gustafsson, D.L. Kukis, A.Y. Louie, Synthesis of
64
Cu-labeled magnetic
nanoparticles for multimodal imaging. Bioconjug. Chem. 19, 1496–1504 (2008)
2 Exogenous Radionanomedicine: Inorganic Nanomaterials
39